ScholarIQanswers from OpenAlex

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines

PaperCitations, authors & open-access status

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines have?

ScholarIQcitation count

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines has 51 citations in the OpenAlex counts ScholarIQ stores.

When was Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines published?

ScholarIQyear

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines has 2017 year in the ScholarIQ index.

What is the open-access status of Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines?

ScholarIQoa status

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines has gold oa status in the ScholarIQ index.

What is the DOI of Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines?

ScholarIQdoi

The DOI for Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines is on the source record.

What is the PMID of Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines?

ScholarIQpmid

The PMID for Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines is on the source record.

What is the OpenAlex record for Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines?

ScholarIQopenalex

The OpenAlex for Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial